Dimensional Fund Advisors
JANX icon

Dimensional Fund Advisors’s Janux Therapeutics JANX Stock Holding History

Dimensional Fund Advisors’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.63M Buy
441,288
+81,563
+23% +$1.37M ﹤0.01% 2367
2026
Q2 		$5.53M Buy
359,725
+263,095
+272% +$3.81M ﹤0.01% 2511
2026
Q1 		$1.34M Sell
96,630
-127,664
-57% -$1.75M ﹤0.01% 2786
2025
Q4 		$3.1M Sell
224,294
-16,337
-7% -$384K ﹤0.01% 2640
2025
Q3 		$5.88M Buy
240,631
+101,970
+74% +$2.48M ﹤0.01% 2494
2025
Q2 		$3.2M Buy
138,661
+121,711
+718% +$3.21M ﹤0.01% 2634
2025
Q1 		$460K Sell
16,950
-3,098
-15% -$117K ﹤0.01% 3014
2024
Q4 		$1.07M Sell
20,048
-324
-2% -$17.1K ﹤0.01% 2897
2024
Q3 		$926K Sell
20,372
-3,647
-15% -$159K ﹤0.01% 2925
2024
Q2 		$1M Buy
24,019
+8,422
+54% +$395K ﹤0.01% 2908
2024
Q1 		$587K Buy
+15,597
New +$340K ﹤0.01% 3017

Other funds holding JANX

Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Jackson Creek Investment Advisors
Jackson Creek Investment Advisors Castle Rock, Colorado $292M AUM 56.98% 1-Year Est. Return

Dimensional Fund Advisors's JANX Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Janux Therapeutics (JANX) stake by 23% in Q3 2026, buying an estimated $1.37M and bringing the position to 441,288 shares worth $7.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Dimensional Fund Advisors first reported a position in JANX in Q1 2024 and has held it in 11 quarters since. 61 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • Dimensional Fund Advisors held 441,288 shares of Janux Therapeutics worth $7.63M as of Q3 2026.
  • Dimensional Fund Advisors bought 81,563 Janux Therapeutics shares in Q3 2026, an estimated $1.37M.
  • Janux Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2367 holding.
  • Dimensional Fund Advisors first reported a position in Janux Therapeutics in Q1 2024 and has held it in 11 quarters since.
  • 61 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.